Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
MGRC
|
David M Whitney
SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 104 Reduced 1.93% |
$8,291
$79.72 p/Share
|
Mar 01
2022 |
MGRC
|
David M Whitney
SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Indirect | 193 Reduced 3.69% |
$15,386
$79.72 p/Share
|
Mar 01
2022 |
MGRC
|
David M Whitney
SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 200 Added 3.58% |
-
|
Mar 01
2022 |
MGRC
|
David M Whitney
SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 380 Added 6.77% |
-
|
Mar 01
2022 |
MGRC
|
Kristina Van Trease
Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 193 Reduced 3.69% |
$15,386
$79.72 p/Share
|
Mar 01
2022 |
MGRC
|
Kristina Van Trease
Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Indirect | 104 Reduced 1.93% |
$8,291
$79.72 p/Share
|
Mar 01
2022 |
MGRC
|
Kristina Van Trease
Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 380 Added 6.77% |
-
|
Mar 01
2022 |
MGRC
|
Kristina Van Trease
Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 200 Added 3.58% |
-
|
Mar 01
2022 |
MD
|
Mark S Ordan
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 20,691 Reduced 5.31% |
$485,618
$23.47 p/Share
|
Mar 01
2022 |
MD
|
Mark S Ordan
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 152,506 Added 28.14% |
-
|
Mar 01
2022 |
MD
|
Dominic J Andreano
EVP, General Counsel and Secy |
SELL
Payment of exercise price or tax liability
|
Direct | 6,635 Reduced 3.31% |
$155,723
$23.47 p/Share
|
Mar 01
2022 |
MD
|
Dominic J Andreano
EVP, General Counsel and Secy |
BUY
Grant, award, or other acquisition
|
Direct | 58,824 Added 22.7% |
-
|
Mar 01
2022 |
MD
|
Mary Ann E Moore
EVP, GC, Chief Admin Off & Sec |
SELL
Payment of exercise price or tax liability
|
Direct | 1,525 Reduced 3.25% |
$35,792
$23.47 p/Share
|
Mar 01
2022 |
MD
|
Mary Ann E Moore
EVP, GC, Chief Admin Off & Sec |
BUY
Grant, award, or other acquisition
|
Direct | 32,680 Added 41.07% |
-
|
Mar 01
2022 |
MD
|
C Marc Richards
EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,874 Reduced 4.49% |
$161,333
$23.47 p/Share
|
Mar 01
2022 |
MD
|
C Marc Richards
EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 61,003 Added 28.5% |
-
|
Mar 01
2022 |
MD
|
Roger Mack Hinson
Pres., PDX & OBX Medical Group |
SELL
Payment of exercise price or tax liability
|
Direct | 10,244 Reduced 8.56% |
$240,427
$23.47 p/Share
|
Mar 01
2022 |
FLYW
|
Rob Orgel
President and COO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$535,600
$26.78 p/Share
|
Mar 01
2022 |
FLYW
|
Rob Orgel
President and COO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 50.0% |
$66,000
$3.3 p/Share
|
Mar 01
2022 |
AEO
|
Jennifer M. Foyle
Global Brand President-aerie |
SELL
Payment of exercise price or tax liability
|
Direct | 20,960 Reduced 16.52% |
$429,470
$20.49 p/Share
|
Mar 01
2022 |
AEO
|
Jennifer M. Foyle
Global Brand President-aerie |
BUY
Grant, award, or other acquisition
|
Direct | 37,902 Added 23.0% |
-
|
Mar 01
2022 |
AEO
|
Michael R Rempell
EVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 13,450 Reduced 7.57% |
$275,590
$20.49 p/Share
|
Mar 01
2022 |
AEO
|
Michael R Rempell
EVP, Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct | 26,345 Added 12.92% |
-
|
Mar 01
2022 |
AEO
|
Jay L Schottenstein
Exec Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 32,125 Reduced 2.35% |
$658,241
$20.49 p/Share
|
Mar 01
2022 |
AEO
|
Jay L Schottenstein
Exec Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 79,221 Added 5.48% |
-
|
Mar 01
2022 |
AEO
|
Michael A. Mathias
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 719 Reduced 3.9% |
$14,732
$20.49 p/Share
|
Mar 01
2022 |
AEO
|
Michael A. Mathias
EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 2,486 Added 11.87% |
-
|
Mar 01
2022 |
AEO
|
Andrew J. Mc Lean
EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 9,450 Reduced 15.25% |
$193,630
$20.49 p/Share
|
Mar 01
2022 |
AEO
|
Andrew J. Mc Lean
EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 17,087 Added 21.61% |
-
|
Mar 01
2022 |
AEO
|
Stacy Siegal
EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,697 Reduced 13.84% |
$75,752
$20.49 p/Share
|
Mar 01
2022 |
AEO
|
Stacy Siegal
EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 9,445 Added 26.12% |
-
|
Mar 01
2022 |
SJW
|
A Kristen Johnson
Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct | 90 Added 0.45% |
-
|
Mar 01
2022 |
SJW
|
Maureen P Westbrook
President of CTWS |
BUY
Grant, award, or other acquisition
|
Direct | 134 Added 0.31% |
-
|
Mar 01
2022 |
BCRX
|
Michael L Jones
Exec. Director, Finance - PAO |
SELL
Open market or private sale
|
Direct | 2,300 Reduced 17.04% |
$39,560
$17.2 p/Share
|
Mar 01
2022 |
BCRX
|
Michael L Jones
Exec. Director, Finance - PAO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,300 Added 14.56% |
$10,879
$4.73 p/Share
|
Mar 01
2022 |
SBCF
|
Joseph M Forlenza
EVP & CRO |
BUY
Grant, award, or other acquisition
|
Direct | 5,768 Added 34.85% |
-
|
Mar 01
2022 |
SBCF
|
Dennis S Hudson Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 17,945 Added 9.42% |
-
|
Mar 01
2022 |
SBCF
|
Tracey Dexter
EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 1,409 Added 17.78% |
-
|
Mar 01
2022 |
SBCF
|
Charles M Shaffer
Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 10,253 Added 15.35% |
-
|
Mar 01
2022 |
SBCF
|
Juliette Kleffel
EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,048 Added 17.33% |
-
|
Mar 01
2022 |
YELP
|
Christine Barone
Director |
BUY
Grant, award, or other acquisition
|
Direct | 996 Added 4.59% |
-
|
Mar 01
2022 |
YELP
|
Robert Lane Gibbs
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,254 Added 2.79% |
-
|
Mar 01
2022 |
YELP
|
Fred D Anderson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,467 Added 6.58% |
-
|
Mar 01
2022 |
YELP
|
Diane M Irvine
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,560 Added 4.05% |
-
|
Mar 01
2022 |
YELP
|
Royce A. Wells
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,065 Added 8.68% |
-
|
Mar 01
2022 |
SSTK
|
Jonathan Oringer
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 21,253 Reduced 0.18% |
$1,909,795
$89.86 p/Share
|
Mar 01
2022 |
GBT
|
Ted W Love
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 9,445 Added 1.17% |
-
|
Mar 01
2022 |
GBT
|
Ted W Love
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,074 Reduced 0.51% |
$121,690
$29.87 p/Share
|
Mar 01
2022 |
GBT
|
Jeffrey S Farrow
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,315 Reduced 4.58% |
$39,279
$29.87 p/Share
|
Mar 01
2022 |
GBT
|
Jeffrey S Farrow
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,763 Added 8.77% |
-
|
Mar 01
2022 |